calmidazolium has been researched along with staurosporine aglycone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brödemann, R; Kase, H; Matthies, H; Reymann, KG | 1 |
Borosky, SA; Boxer, PA; Coughenour, LL; Hajimohammadreza, I; Marcoux, FW; Probert, AW; Wang, KK | 1 |
2 other study(ies) available for calmidazolium and staurosporine aglycone
Article | Year |
---|---|
Inhibitors of calmodulin and protein kinase C block different phases of hippocampal long-term potentiation.
Topics: Action Potentials; Animals; Calmodulin; Carbazoles; Electric Stimulation; Enzyme Inhibitors; Hippocampus; Imidazoles; In Vitro Techniques; Indole Alkaloids; Protein Kinase C; Rats; Rats, Inbred Strains | 1988 |
A specific inhibitor of calcium/calmodulin-dependent protein kinase-II provides neuroprotection against NMDA- and hypoxia/hypoglycemia-induced cell death.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Carbazoles; Cell Death; Cell Hypoxia; Cell Survival; Cells, Cultured; Cerebral Cortex; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fetus; Genistein; Imidazoles; Indole Alkaloids; Isoflavones; Isoquinolines; Kinetics; N-Methylaspartate; Naphthalenes; Neurons; Piperazines; Polycyclic Compounds; Protein Kinase C; Protein Kinase Inhibitors; Rats; Rats, Sprague-Dawley; Spectrin | 1995 |